These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24769813)

  • 1. Association between phosphorylated AMP-activated protein kinase and acetyl-CoA carboxylase expression and outcome in patients with squamous cell carcinoma of the head and neck.
    Su YW; Lin YH; Pai MH; Lo AC; Lee YC; Fang IC; Lin J; Hsieh RK; Chang YF; Chen CL
    PLoS One; 2014; 9(4):e96183. PubMed ID: 24769813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of phospho-acetyl-CoA carboxylase protein is an independent prognostic factor for human gastric cancer without lymph node metastasis.
    Fang W; Cui H; Yu D; Chen Y; Wang J; Yu G
    Med Oncol; 2014 Jul; 31(7):15. PubMed ID: 24924473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of phosphorylated AMP-activated protein kinase expression on lung cancer survival.
    William WN; Kim JS; Liu DD; Solis L; Behrens C; Lee JJ; Lippman SM; Kim ES; Hong WK; Wistuba II; Lee HY
    Ann Oncol; 2012 Jan; 23(1):78-85. PubMed ID: 21430184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of the Overexpression of Fatty Acid Metabolism-Related Enzymes in Squamous Cell Carcinoma of the Head and Neck.
    Su YW; Wu PS; Lin SH; Huang WY; Kuo YS; Lin HP
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylated Acetyl-CoA Carboxylase Is Associated with Clinical Benefit with Regorafenib in Relapsed Glioblastoma: REGOMA Trial Biomarker Analysis.
    Indraccolo S; De Salvo GL; Verza M; Caccese M; Esposito G; Piga I; Del Bianco P; Pizzi M; Gardiman MP; Eoli M; Rudà R; Brandes AA; Ibrahim T; Rizzato S; Lolli I; Zagonel V; Lombardi G
    Clin Cancer Res; 2020 Sep; 26(17):4478-4484. PubMed ID: 32518098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinoma.
    Zhang H; Kim S; Chen Z; Nannapaneni S; Chen AY; Moore CE; Sica G; Mosunjac M; Nguyen MLT; D'Souza G; Carey TE; Peterson LA; McHugh JB; Graham M; Komarck CM; Wolf GT; Walline HM; Bellile E; Riddell J; Pai SI; Sidransky D; Westra WH; William WN; Lee JJ; El-Naggar AK; Ferris RL; Seethala R; Grandis JR; Chen ZG; Saba NF; Shin DM;
    Head Neck; 2017 Dec; 39(12):2433-2443. PubMed ID: 28945296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between phosphorylated AMP-activated protein kinase and MAPK3/1 expression and prognosis for patients with gastric cancer.
    Kim JG; Lee SJ; Chae YS; Kang BW; Lee YJ; Oh SY; Kim MC; Kim KH; Kim SJ
    Oncology; 2013; 85(2):78-85. PubMed ID: 23860205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab.
    Luo J; Hong Y; Lu Y; Qiu S; Chaganty BK; Zhang L; Wang X; Li Q; Fan Z
    Cancer Lett; 2017 Jan; 384():39-49. PubMed ID: 27693630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of AMPK activation in advanced stage colorectal cancer treated with chemotherapy plus bevacizumab.
    Zulato E; Bergamo F; De Paoli A; Griguolo G; Esposito G; De Salvo GL; Mescoli C; Rugge M; Nardin M; Di Grazia L; Lonardi S; Indraccolo S; Zagonel V
    Br J Cancer; 2014 Jul; 111(1):25-32. PubMed ID: 24892446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMPK and ACCchange with fasting and physiological condition in euthermic and hibernating golden-mantled ground squirrels (Callospermophilus lateralis).
    Healy JE; Gearhart CN; Bateman JL; Handa RJ; Florant GL
    Comp Biochem Physiol A Mol Integr Physiol; 2011 Jul; 159(3):322-31. PubMed ID: 21473923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.
    Baschnagel AM; Williams L; Hanna A; Chen PY; Krauss DJ; Pruetz BL; Akervall J; Wilson GD
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):701-7. PubMed ID: 24521684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated expression of T-lymphoma invasion and metastasis inducing factor 1 in squamous-cell carcinoma of the head and neck and its clinical significance.
    Wang S; Li S; Yang X; Yang S; Liu S; Liu B; Liu J
    Eur J Cancer; 2014 Jan; 50(2):379-87. PubMed ID: 24189000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic role of regenerating gene-I in patients with stage-IV head and neck squamous cell carcinoma.
    Aboshanif M; Kawasaki Y; Omori Y; Suzuki S; Honda K; Motoyama S; Ishikawa K
    Diagn Pathol; 2016 Aug; 11(1):79. PubMed ID: 27539087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
    Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y
    BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck.
    Hirshoren N; Danne J; Dixon BJ; Magarey M; Kleid S; Webb A; Tiong A; Corry J; Gyorki D
    Head Neck; 2017 Apr; 39(4):772-778. PubMed ID: 28199044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent cetuximab and postoperative radiation in resected high-risk squamous cell carcinomas of the head and neck: A single-institution experience.
    Araki D; Redman MW; Martins R; Eaton K; Baik C; Chow L; Goulart B; Lee S; Santana-Davila R; Liao J; Parvathaneni U; Laramore G; Futran N; Mendez E; Bhrany A; Rodriguez CP
    Head Neck; 2016 Sep; 38(9):1318-23. PubMed ID: 27061333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of elevated protein kinase CK2 activity with aggressive behavior of squamous cell carcinoma of the head and neck.
    Gapany M; Faust RA; Tawfic S; Davis A; Adams GL; Ahmed K
    Mol Med; 1995 Sep; 1(6):659-66. PubMed ID: 8529132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03.
    Le QT; Harris J; Magliocco AM; Kong CS; Diaz R; Shin B; Cao H; Trotti A; Erler JT; Chung CH; Dicker A; Pajak TF; Giaccia AJ; Ang KK
    J Clin Oncol; 2009 Sep; 27(26):4281-6. PubMed ID: 19667273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent prognostic role of PD-L1expression in patients with esophageal squamous cell carcinoma.
    Jiang D; Song Q; Wang H; Huang J; Wang H; Hou J; Li X; Xu Y; Sujie A; Zeng H; Tan L; Hou Y
    Oncotarget; 2017 Jan; 8(5):8315-8329. PubMed ID: 28039448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SMYD2 overexpression is associated with tumor cell proliferation and a worse outcome in human papillomavirus-unrelated nonmultiple head and neck carcinomas.
    Ohtomo-Oda R; Komatsu S; Mori T; Sekine S; Hirajima S; Yoshimoto S; Kanai Y; Otsuji E; Ikeda E; Tsuda H
    Hum Pathol; 2016 Mar; 49():145-55. PubMed ID: 26826421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.